Turkey: The Board published its reasoned decision on Roche Müstahzarları Sanayi A.Ş.’s request for granting individual exemption to the exclusive tender store agreement concluded with MTS İlaç Dağıtım Ticaret A.Ş

Last Updated: 16 March 2017
Practice Guide by ELIG, Attorneys-at-Law

The Board published its reasoned decision on Roche Müstahzarları Sanayi A.Ş.’s request for granting individual exemption to the exclusive tender store agreement concluded with MTS İlaç Dağıtım Ticaret A.Ş. (16.11.2016, 16-39/642-288).

The Turkish Competition Board (“Board”) recently published its reasoned decision on the Roche Müstaharları Sanayi A.Ş.’s (“Roche”) request for granting individual exemption to the exclusive tender store agreement concluded with MTS İlaç Dağıtım Ticaret A.Ş. (“MTS”). Roche, that is the Turkish subsidiary of F. Hoffmann-La Roche Ltd. based in Basel, Switzerland, is active in the sectors for medicine for human use and diagnostic equipment. MTS, that is based in Istanbul, is involved in the wholesale trade of basic pharmaceutics products and pharmaceutical preparations.

In its decision, the Board firstly analyzed whether the agreement could be granted negative clearance. In this regard, the Board determined that the agreement that is subject to notification exclusively authorized MTS to follow the tenders that are initiated in scope of the Public Tender Act numbered 4734 (“Law No. 4734”), to participate and to bid Roche’s products in such tenders. Although the agreement does not include provisions regarding resale price maintenance except for a maximum sales price. The Board stated that it is not possible to grant negative clearance to the agreement, due to the exclusivity and non-compete obligations provided within the agreement.

Afterwards, the Board analyzed whether the agreement could benefit from the block exemption that is provided under the Block Exemption Communiqué No. 2002/2 on the Vertical Agreements (“Communiqué No. 2002/2”). In this regard, the Board found the agreement could not be granted block exemption, since the non-compete provisions provided under the agreement were found to be contradictory with the Communiqué No. 2002/2, on the basis of the duration of the non-compete obligations and the persons and/or institutions (other than MTS) that could be subject to the effects of the such obligations, which are more restrictive than what is provided under the Communiqué No. 2002/2. Therefore the Board assessed that the agreement should be analyzed in scope of the terms of individual exemption.

In this regard, the Board analyzed the agreement in scope of the conditions set out under Article 5 of Law No. 4054. In order for an agreement to be granted individual exemption;

  1. the agreement must contribute to improving the production or distribution of goods or to promoting technical or economic progress,
  2. it must allow consumers a fair share of the resulting benefit,
  3. it should not eliminate competition in a significant part of the relevant market,
  4. it should not limit competition more than what is compulsory for achieving the goals set out in sub-paragraphs (i) and (ii) above.

The Board found that the relevant agreement provides supply persistency and regular flow of information, which enables Roche to conduct proper planning and keep sufficient stock in proportion to MTS’s tender results. The Board has also indicated that the concrete information provided by the parties support the findings regarding the terms of the agreement. Therefore, the Board found that the agreement satisfies the first condition provided under Article 5 of Law No. 4054.

The Board has also found that the agreement would have positive effects on the state’s drug expenditures. Therefore, the Board has indicated that while the agreement satisfied the supply persistency condition, it will also provide for progress as regards the treatment of inpatients. In this regard, the Board assessed that the agreement also satisfied the condition provided under Article 5(b) of Law No. 4054.

As regards the third condition, the Board stated that there are quite a few pharmaceutical warehouses, which operate for tender sales and therefore, the agreement would not eliminate competition in a significant part of the relevant market. In this respect, the Board found that the agreement further satisfied the third condition provided under Article 5 of Law No. 4054.

Finally, the Board explained that, the competition might be limited in the absence of non-compete obligations, namely in cases where the competing suppliers separately conclude exclusive agreements with the same warehouse. The Board stated that, due to the fact that offering alternative products in drug tenders are restricted, the pharmaceutical warehouse which has separate exclusive agreements with competing suppliers would only be able to offer one of the competing products, in which case, only one of the competing products would be represented in the relevant tender. The Board assessed that, the non-compete obligations eliminate the explained drawback. Yet, the Board indicated that the scope of non-compete obligation must be justifiable and in proportion with the expected gains of the agreement.

In this regard, the Board referred to Article 11.2. of the relevant agreement which takes MTS’s shareholders and/or affiliates into the scope of the non-compete obligation and stated that the agreement could be deemed as proportionate to the extent that the non-compete obligation solely covers MTS and the persons who have a control relationship with MTS. Therefore the Board assessed that Article 11.2. of the agreement should be amended in a way that the shareholders and affiliates are excluded from the scope of the non-compete provisions.  The Board has also found that Article 11.2. of the agreement is drafted in such a way that the sales of MTS might be restricted beyond the tender sales. However the Board indicated that, in order for the agreement to be deemed proportionate, the non-compete obligation should only cover MTS’s sales in scope of the tenders. Therefore the Board assessed that the relevant article must be amended in a way that the non-compete obligation only applies to MTS’s sales in tenders that constitute the subject of the relevant agreement.  Therefore the Board found that the fourth condition provided under the Article 5 of Law No. 4054 would be satisfied if Roche amends the agreement in line with the concerns explained above.

In light of the above, the Board concluded that the agreement could be granted individual exemption on the condition that Roche amends Article 11.2. of the agreement in a way that (i) the non-compete provisions would solely impose obligations on MTS and the persons who have control over MTS and that (ii) the non-compete obligations would be limited to MTS’s sales in the relevant tenders that constitute the subject of the agreement.

This document is not intended to create an attorney-client relationship. You should not act or rely on any information in this document without first seeking legal advice. This material is intended for general information purposes only and does not constitute legal advice. If you have any specific questions on any legal matter, you should consult a professional legal services provider.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Contact the Author?
Click here to email the Author
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Other Turkey Advice Centres
Intellectual Property
Privacy and Data Protection
More Advice Centers
Significant Recent Cases
Turkish Competition Board case summaries.
Useful Resources
A collection of articles, essays and reports written by our experts.
The most recent developments within our firm and practice areas.
Upcoming Events
Information on upcoming or recent events and conferences hosted by ELIG.
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.